Stem Cell Trial Seeks Longer Lives for Victims of Deadly ALS
January 8, 2014
Reuters / Powered by NewsLook.com
Researchers at Emory University in the United States are hoping to extend the lives of patients diagnosed with the deadly neuro-degenerative disease, Amyotrophic lateral sclerosis (ALS). ALS kills by destroying a patient's nervous system but in clinical trials, the scientists say injections of neural stem cells show promise in slowing the disease's progress. Ben Gruber reports.
Newsy (May 15, 2014) The mice were given human stem cells to test stem cell rejection. But instead of rejecting the human cells, the mice began to show positive reactions.
Video provided by ... watch video
Reuters (June 3, 2013) Researchers at the Harvard Stem Cell Institute have identified a blood protein they say can reverse the aging process in mouse hearts. After introducing the protein into the hearts of old mice, the ... watch video
AFP (Feb. 21, 2014) Indonesia institutes the world's biggest manta ray sanctuary covering millions of square kilometres as it seeks to protect the huge winged fish and draw more tourists to the sprawling archipelago. ... watch video
AFP (Nov. 29, 2015) As Hong Kong seeks to expand its international airport and with a major new bridge project under way, campaigners warn that the dwindling number of pink dolphins in the already busy surrounding ... watch video
Apr. 30, 2016 New research found many products marketed as 'first finger foods' for babies failed to meet American Academy of Pediatrics recommendations that they be small, soft and easy to ... read more
Apr. 27, 2016 Tiny electronic sensors and devices that can be implanted in the body and then dissolve almost without a trace are getting closer to reality. Scientists have tested several ... read more
June 26, 2014 Scientists have demonstrated in fruit-flies that over-activity of the enzyme HDAC6 in the nerve ends exacerbates the symptoms of the neurodegenerative condition Amyotrophic Lateral Sclerosis (ALS / ... read more
Oct. 25, 2013 Researchers will soon begin phase IIa clinical trials of TDI-132, a drug that in animal models has shown promise in reducing the inflammation associated with Amyotrophic Lateral ... read more
Dec. 19, 2012 Transplanting neural stem cells into an ALS mouse model slows disease progression and prolongs survival. The transplanted neural stem cells changed the host environment for the better and protected ... read more